The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouhlal, H.
Right arrow Articles by Haeffner Cavaillon, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouhlal, H.
Right arrow Articles by Haeffner Cavaillon, N.
The Journal of Immunology, 2001, 166: 3377-3383.
Copyright © 2001 by The American Association of Immunologists

Soluble CD16 Inhibits CR3 (CD11b/CD18)-Mediated Infection of Monocytes/Macrophages by Opsonized Primary R5 HIV-11

Hicham Bouhlal*, Jérôme Galon{dagger}, Michel D. Kazatchkine*, Wolf-Herman Fridman{dagger}, Catherine Sautès-Fridman{dagger} and Nicole Haeffner Cavaillon2,*

* Institut National de la Santé et de la Recherche Médicale Unité 430, Hôpital Broussais; and {dagger} Institut National de la Santé et de la Recherche Médicale Unité 255, Institut Curie, Paris, France

We demonstrate that soluble CD16 (sCD16; soluble Fc{gamma}RIII), a natural ligand of CR3, inhibits the infection of monocytes by primary R5 HIV-1 strain opsonized with serum of seronegative individuals. Inhibition of monocyte infection by sCD16 was similar to that observed with anti-CR3 mAbs, indicating that opsonized HIV may use a CR3-dependent pathway for entry in monocytic cells. Cultured human monocytes express both CR3 (CD11b/CD18) and CCR5 receptors. RANTES, the natural ligand of CCR5, inhibited infection of monocytes with unopsonized HIV particles and partially that of monocytes infected with HIV particles opsonized with complement-derived fragments. Although HIV-infected monocytes from homozygous CCR5 {Delta} 32/{Delta} 32 (CCR5-/-) individuals produce low levels of p24, cells infected with opsonized particles produced higher levels of p24 than cells infected with unopsonized particles. Our results thus suggest that CR3 may represent an alternative coreceptor to CCR5 of opsonized primary R5 virus entry into monocytes/macrophages. We also observed that the concentration of sCD16 is greatly decreased in sera of HIV-infected patients with low lymphocyte CD4+ counts. Taken together, our findings suggest that sCD16, present in plasma, may play an important role in controlling HIV-1 spread.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Bouhlal, N. Chomont, M. Requena, N. Nasreddine, H. Saidi, J. Legoff, M. D. Kazatchkine, L. Belec, and H. Hocini
Opsonization of HIV with Complement Enhances Infection of Dendritic Cells and Viral Transfer to CD4 T Cells in a CR3 and DC-SIGN-Dependent Manner
J. Immunol., January 15, 2007; 178(2): 1086 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Bajtay, C. Speth, A. Erdei, and M. P. Dierich
Cutting Edge: Productive HIV-1 Infection of Dendritic Cells via Complement Receptor Type 3 (CR3, CD11b/CD18)
J. Immunol., October 15, 2004; 173(8): 4775 - 4778.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Bouhlal, N. Chomont, N. Haeffner-Cavaillon, M. D. Kazatchkine, L. Belec, and H. Hocini
Opsonization of HIV-1 by Semen Complement Enhances Infection of Human Epithelial Cells
J. Immunol., September 15, 2002; 169(6): 3301 - 3306.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M.-P. Carreno, N. Chomont, M. D. Kazatchkine, T. Irinopoulou, C. Krief, A.-S. Mohamed, L. Andreoletti, M. Matta, and L. Belec
Binding of LFA-1 (CD11a) to Intercellular Adhesion Molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) Triggers Transmigration of Human Immunodeficiency Virus Type 1-Infected Monocytes through Mucosal Epithelial Cells
J. Virol., January 1, 2002; 76(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Marechal, M.-C. Prevost, C. Petit, E. Perret, J.-M. Heard, and O. Schwartz
Human Immunodeficiency Virus Type 1 Entry into Macrophages Mediated by Macropinocytosis
J. Virol., November 15, 2001; 75(22): 11166 - 11177.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.